Cancer drug approved for arthritis treatment

03/2/2006 | USA Today

The FDA said a Genentech and Biogen Idec cancer drug can also be used to treat rheumatoid arthritis if other remedies fail. Rituxan, the country's best-selling cancer drug, originally was approved eight years ago to treat non-Hodgkin's lymphoma.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ